NVT GmbH develops, manufactures and markets medical devices for interventional cardiology and cardiac surgery from its headquarters in Hechingen, collaborating with medical institutions and physicians. Its flagship product is the Allegra transcatheter aortic valve implantation system; CE marking was granted in 2017 and the valve-in-valve indication in 2020. Development and production take place at the Hechingen site; the company is part of the Blue Sail Medical group and distributes worldwide via the Biosensors International Group network. In fiscal year 2024 NVT reported revenue of EUR 18.99m, a net profit of EUR 669,074.07, employed 110 people and spent EUR 3.48m on research and development.
Die Entwicklung und Herstellung von Herzklappen und weiteren medizintechnischen Produkten.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 735335 (as of 12 October 2026)
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 735335 (as of 12 October 2026)
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 735335 (as of 12 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 735335 (as of 12 October 2026)
